Efficacy of combination treatment with intracoronary abciximab and aspiration thrombectomy on myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary coronary stenting.
PURPOSE
We aimed to investigate whether combination therapy using intracoronary (IC) abciximab and aspiration thrombectomy (AT) enhances myocardial perfusion compared to each treatment alone in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).


MATERIALS AND METHODS
We enrolled 40 patients with STEMI, who presented within 6 h of symptom onset and had Thrombolysis in MI flow 0/1 or a large angiographic thrombus burden (grade 3/4). Patients were randomly divided into 3 groups: 10 patients who received a bolus of IC abciximab (0.25 mg/kg); 10 patients who received only AT; and 20 patients who received both treatments. The index of microcirculatory resistance (IMR) was measured with a pressure sensor/thermistor-tipped guidewire following successful PCI. Microvascular obstruction (MVO) was assessed using cardiac magnetic resonance imaging on day 5.


RESULTS
IMR was lower in the combination group than in the IC abciximab group (23.5±7.4 U vs. 66.9±48.7 U, p=0.001) and tended to be lower than in the AT group, with barely missed significance (23.5±7.4 U vs. 37.2±26.1 U, p=0.07). MVO was observed less frequently in the combination group than in the IC abciximab group (18.8% vs. 88.9%, p=0.002) and tended to occur less frequently than in the AT group (18.8% vs. 66.7%, p=0.054). No difference of IMR and MVO was found between the IC abciximab and the AT group (66.9±48.7 U vs. 37.2±26.1 U, p=0.451 for IMR; 88.9% vs. 66.7%, p=0.525 for MVO, respectively).


CONCLUSION
Combination treatment using IC abciximab and AT may synergistically improve myocardial perfusion in patients with STEMI undergoing primary PCI (Trial Registration: clinicaltrials. gov Identifier: NCT01404507).
['Ahn|Sung Gyun|SG|', 'Lee|Seung-Hwan|SH|', 'Lee|Ji Hyun|JH|', 'Lee|Jun-Won|JW|', 'Youn|Young Jin|YJ|', 'Ahn|Min-Soo|MS|', 'Kim|Jang-Young|JY|', 'Yoo|Byung-Su|BS|', 'Yoon|Junghan|J|', 'Choe|Kyung-Hoon|KH|', 'Tahk|Seung-Jea|SJ|']
D000077284:Abciximab D000293:Adolescent D000328:Adult D000368:Aged D015906:Angioplasty, Balloon, Coronary D000911:Antibodies, Monoclonal D005260:Female D006801:Humans D007140:Immunoglobulin Fab Fragments D008297:Male D008875:Middle Aged D009203:Myocardial Infarction D017131:Thrombectomy D055815:Young Adult
Abciximab myocardial perfusion myocardial infarction thrombosuction